Gilgamesh Pharmaceuticals logo

Gilgamesh Pharmaceuticals Funding & Investors

Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose is to accelerate treatments and fundamentally improve mental health.

gilgameshpharmaceutical.com

Total Amount Raised: $82,559,840

Gilgamesh Pharmaceuticals Funding Rounds

  • Grant

    $14,000,000

    Grant Investors

    National Institute on Drug Abuse (NIDA)
  • Series B

    $39,000,000

    Series B Investors

    Prime Movers Lab
    Gron Ventures
    Negev Capital
    Alumni Ventures
    Palo Santo
    Satori Capital
    Route 66 Ventures
    JLS Fund
    WPSS.bio
  • Series A

    $27,000,000

    Series A Investors

    Prime Movers Lab
    Noetic Fund
    Route 66 Ventures
    Gron Ventures
    JLS Fund
    Palo Alto Investors
    What If Ventures
    Gaingels
    Alumni Ventures
    Arda Kara
  • Seed

    $125,000

    Seed Investors

    Y Combinator
    What If Ventures
    Offline Ventures
    Bossa Nova Investimentos
    Incisive Ventures
  • Seed

    $2,434,845

    Seed Investors

    Rand Hindi
    Noveus Capital
Funding info provided by Diffbot.